Skip to content

Pilot Study to Assess Feasibility, Reliability and Validity of the e-SSRS-IVR

Pilot Study to Assess Feasibility, Reliability and Validity of the e-SSRS-IVR

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00921466
Acronym
e-SSRS-IVR
Enrollment
20
Registered
2009-06-16
Start date
2009-06-30
Completion date
2009-08-31
Last updated
2009-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Evaluate the clinical content of the e-SSRS-IVR

Brief summary

The proposed study is designed to evaluate the clinical contents of the e-SSRS-IVR with respect to 1.the intent of the instrument (assess face and content validity), 2. system validation with respect to programming integrity, 3. implementation feasibility in clinical ill and healthy patient populations, and 4. criterion/predictive validity to discriminate patient population with known clinical status differences.

Interventions

None listed

Sponsors

GlaxoSmithKline
CollaboratorINDUSTRY
Rogers Center for Research & Training, Inc.
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* English speaking adults, able/willing to read and provide written consent

Exclusion criteria

* Dementia, delirium, psychosis or deafness. * Control subjects will be excluded for any MINI lifetime MDD or dysthymia diagnosis of a DSM-IV disorder except for specific phobia or dependence on nicotine and caffeine. * Inpatients not admitted with suicidal ideations

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026